Compare CUBI & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUBI | AXGN |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | 869 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | 2013 |
| Metric | CUBI | AXGN |
|---|---|---|
| Price | $76.58 | $39.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $85.00 | $42.33 |
| AVG Volume (30 Days) | 320.7K | ★ 1.4M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $24.95 | $20.57 |
| Revenue Next Year | $9.50 | $16.68 |
| P/E Ratio | $11.78 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $59.34 | $12.39 |
| 52 Week High | $82.56 | $46.95 |
| Indicator | CUBI | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 43.09 |
| Support Level | $72.04 | $38.61 |
| Resistance Level | $79.38 | $39.99 |
| Average True Range (ATR) | 1.74 | 1.81 |
| MACD | -0.20 | -0.27 |
| Stochastic Oscillator | 35.81 | 18.62 |
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.